|
Founded in 1992, RM Global Partners is an investment banking firm headquartered in New York, New York. The firm assists its clients in mergers and acquisitions, divestitures, spin-offs, joint ventures, structures transactions, spin-offs, private placements, bridge financings, and debt. In addition, RM Global Partners offers services in the areas of business development, project assessment, due diligence, valuations, fairness opinions, and corporate strategy. RMGP Biopharma Investment Fund is a Venture Capital (VC) Fund that invests in innovative, early stage biopharma assets, through its partnership with FutuRx. FutuRx is an Israel-based, globally focused drug development platform, founded by Orbimed, Johnson&Johnson and Takeda. RMGP's partnership with the incubator provides access to projects carefully selected by industry professionals, with potential to be first-in-class or best-in-class treatments for therapeutic areas with high unmet need (e.g.: oncology, rare diseases, autoimmune diseases, cardiovascular and metabolic diseases, neurodegenerative and other CNS disorders).
|